MIRA Pharmaceuticals (NASDAQ:MIRA)

BRIEF

published on 12/19/2024 at 15:05, 1 day 22 hours ago

MIRA Pharmaceuticals soumet une demande d'IND pour Ketamir-2 à la FDA

Ketamir-2 Récepteur NMDA Douleur Neuropathique Soumission D'IND Auprès De La FDA Essais Cliniques De Phase I
BRIEF

published on 12/19/2024 at 15:05, 1 day 22 hours ago

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA

Ketamir-2 NMDA Receptor Neuropathic Pain FDA IND Submission Phase I Clinical Trials
PRESS RELEASE

published on 12/19/2024 at 15:00, 1 day 22 hours ago

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development
MIRA Pharmaceuticals submits IND application for novel oral ketamine analog Ketamir-2 to FDA, targeting neuropathic pain. Phase I trials planned to start in 2025

FDA IND Application MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain
BRIEF

published on 12/10/2024 at 14:35, 10 days 22 hours ago

MIRA Pharmaceuticals Advances Towards Clinical Trials with Ketamir-2

Clinical Trials Ketamir-2 Neuropathic Pain Safety Profile Pharmaceutical Milestone
BRIEF

published on 12/10/2024 at 14:35, 10 days 22 hours ago

MIRA Pharmaceuticals avance vers des essais cliniques avec Ketamir-2

Essais Cliniques Ketamir-2 Douleur Neuropathique Profil De Sécurité Étape Importante Dans Le Secteur Pharmaceutique
PRESS RELEASE

published on 12/10/2024 at 14:30, 10 days 23 hours ago

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End
MIRA Pharmaceuticals successfully completes preclinical safety program for Ketamir-2, paving the way for clinical trials in neuropathic pain. Strategic focus on advancing innovative, safe treatments for patients

Clinical Trials Drug Development MIRA Pharmaceuticals Neuropathic Pain Preclinical Safety Program
BRIEF

published on 11/20/2024 at 13:49, 1 month ago

MIRA Pharmaceuticals Initiates Ketamir-2 Clinical Trials

Clinical Trial MIRA Pharmaceuticals Ketamir-2 PainCart Technology Non-addictive Treatment
BRIEF

published on 11/20/2024 at 13:49, 1 month ago

MIRA Pharmaceuticals lance des essais cliniques sur le kétamir-2

Essai Clinique Ketamir-2 MIRA Pharmaceutique Technologie PainCart Traitement Non Addictif
PRESS RELEASE

published on 11/20/2024 at 13:44, 1 month ago

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
MIRA Pharmaceuticals progresses towards clinical-stage status with Phase I/IIa trial announcement on Ketamir-2, a novel oral ketamine analog, for pain management. CHDR's PainCart technology leveraged

Pain Management MIRA Pharmaceuticals Ketamir-2 Clinical-stage Company Phase I/IIa Trial
BRIEF

published on 10/28/2024 at 12:35, 1 month 24 days ago

MIRA Pharmaceuticals révèle des résultats précliniques prometteurs pour le kétamir-2

Résultats Précliniques Ketamir-2 Douleur Neuropathique MIRA Pharmaceutique Désignation De La FDA

1 2 ... 5

Published on 12/21/2024 at 01:30, 12 hours 2 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 2 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 27 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 32 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 2 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 40 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 47 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 21 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 36 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 32 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 14 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 1 hour 14 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 32 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 19 hours 32 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 37 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News